上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2021 , Vol. 41 >Issue 2: 140 - 146

DOI: https://doi.org/10.3969/j.issn.1674-8115.2021.02.003

论著·基础研究

基质金属蛋白酶响应性G4 PAMAM-IBU/GelMA水凝胶的构建及其特征研究

  • 蔡传栋 ,
  • 王非 ,
  • 崔文国 ,
  • 范存义 ,
  • 刘珅
展开
  • 1.上海交通大学附属第六人民医院骨科，上海 200233
    2.上海交通大学医学院附属瑞金医院骨科，上海市伤骨科研究所，上海市中西医结合防治骨与关节病损重点实验室，上海 200025
蔡传栋（1995—），男，硕士生；电子信箱：caicd123@sina.com。

收稿日期: 2020-06-01

  网络出版日期: 2021-02-28

基金资助

国家自然科学基金面上项目(81772314);上海市教育委员会高峰高原学科建设计划(20191829)

收起

Fabrication and characterization of matrix metalloproteinase-responsive G4 PAMAM-IBU/GelMA hydrogel

  • Chuan-dong CAI ,
  • Fei WANG ,
  • Wen-guo CUI ,
  • Cun-yi FAN ,
  • Shen LIU
Expand
  • 1.Department of Orthopedics, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    2.Department of Orthopedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Institute of Traumatology and Orthopedics; Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai 200025, China

Received date: 2020-06-01

  Online published: 2021-02-28

Supported by

National Natural Science Foundation of China(81772314);Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support(20191829)

Fold

摘要

目的·构建负载第4代树枝状大分子聚酰胺-胺（generation 4 polyamindoamine，G4 PAMAM）/布洛芬（ibuprofen，IBU）复合物（G4 PAMAM-IBU）的基质金属蛋白酶（matrix metalloproteinase，MMP）响应性明胶（gelatin，Gel）水凝胶，并探究其体外特征。方法·将IBU粉末加入G4 PAMAM溶液中，经超声振荡得到G4 PAMAM-IBU复合物，利用紫外分光光度计检测饱和G4 PAMAM-IBU溶液中IBU的浓度，研究G4 PAMAM对IBU的增溶能力和G4 PAMAM-IBU复合物中IBU的释放。采用CCK-8试剂盒评估IBU与G4 PAMAM-IBU对大鼠成纤维细胞增殖的抑制能力。同时，为实现G4 PAMAM-IBU的按需释放，利用Gel与甲基丙烯酸酐的加成反应合成甲基丙烯酸酯明胶（methacrylate gelatin，GelMA），并在365 nm光交联下形成MMP响应性水凝胶，并将G4 PAMAM-IBU复合物包载于该水凝胶之中。扫描电子显微镜观察水凝胶的微观形态，紫外分光光度计测定水凝胶中药物的释放量。之后，将载药GelMA水凝胶与成纤维细胞共培养，采用CCK-8试剂盒与活/死细胞染色法评估水凝胶对成纤维细胞增殖的影响。采用单因素方差分析进行组间定量资料的比较。结果·IBU与G4 PAMAM成功组成复合物，并使IBU在水中的溶解度显著提高，且IBU在12 h内与G4 PAMAM逐渐解离并释放。与空白对照组相比，单纯的IBU浓度需达到300 μg/mL才具有抑制成纤维细胞增殖的能力（P=0.023），而G4 PAMAM-IBU中IBU的浓度为100 μg/mL时即可显著抑制成纤维细胞增殖（P=0.000）。所制备的G4 PAMAM-IBU/GelMA水凝胶经MMP处理后，内部孔隙增大，药物释放加快。同时，体外实验发现，与载IBU的GelMA水凝胶相比，G4 PAMAM-IBU/GelMA水凝胶处理后的成纤维细胞活细胞减少，死细胞增多，对细胞增殖的抑制作用显著增强（均P=0.000）；且加入MMP后，抑制作用进一步增强。结论·G4 PAMAM对IBU具有显著的增溶作用并可增强其药物效应；G4 PAMAM-IBU/GelMA水凝胶具有MMP响应性的药物缓释行为，并能够持续抑制成纤维细胞增殖。

关键词： 水凝胶; 第4代聚酰胺-胺; 布洛芬; 肌腱粘连

本文引用格式

蔡传栋 , 王非 , 崔文国 , 范存义 , 刘珅 . 基质金属蛋白酶响应性G4 PAMAM-IBU/GelMA水凝胶的构建及其特征研究[J]. 上海交通大学学报（医学版）, 2021 , 41(2) : 140 -146 . DOI: 10.3969/j.issn.1674-8115.2021.02.003

Abstract

Objective

·To fabricate matrix metalloproteinase (MMP)-responsive gelatin (Gel) hydrogel loaded with generation 4 polyamindoamine (G4 PAMAM)/ibuprofen (IBU) polyplexes (G4 PAMAM-IBU), and investigate its characteristics in vitro.

Methods

·The G4 PAMAM was mixed with IBU powder to form G4 PAMAM-IBU polyplexes under ultrasound vortex. The concentration of IBU in the saturated G4 PAMAM-IBU solution was determined by ultraviolet spectrophotometer. The solubilization ability of G4 PAMAM for IBU and the release of IBU in G4 PAMAM-IBU were assessed. And the ability of IBU and G4 PAMAM-IBU to inhibit the proliferation of rat fibroblasts was verified by CCK-8 assay. Meanwhile, to achieve the on-demand release of G4 PAMAM-IBU, Gel and methacrylic anhydride were used to synthesize methacrylate modified gelatin (GelMA) through an addition reaction, MMP-responsive hydrogel was formed under 365 nm light, and the G4 PAMAM-IBU polyplexes were embedded in the hydrogel. The microscopic morphology of the hydrogel was observed by scanning electron microscope (SEM) and the amount of released IBU was measured by ultraviolet spectrophotometer. Then, drug-loaded GelMA hydrogel was co-cultured with fibroblasts, and the effect of hydrogel on proliferation of fibroblasts was evaluated by CCK-8 assay and live/dead cell staining. The differences in the quantitative data among the groups were analyzed by using one-way ANOVA.

Results

·G4 PAMAM-IBU was formed successfully, the solubility of IBU in water increased obviously, and G4 PAMAM-IBU could gradually dissociate within 12 h and thereby release IBU as well. Compared with the blank control group, the concentration of IBU alone needed to reach 300 μg/mL to inhibit the proliferation of fibroblasts (P=0.023), while the concentration of IBU in G4 PAMAM-IBU was 100 μg/mL to significantly inhibit the proliferation of fibroblasts (P=0.000). The SEM images and released IBU detection results showed that the internal porosity of the prepared G4 PAMAM-IBU/GelMA hydrogel increased and the release of the drug accelerated. Besides, the in vitro results showed that compared with the IBU/GelMA hydrogel, there were less live cells and more dead cells in the G4 PAMAM-IBU/GelMA hydrogel-treated fibroblasts. G4 PAMAM-IBU/GelMA hydrogel had a greater proliferation inhibitory effect than the IBU/GelMA hydrogel. And the addition of MMP further enhanced the inhibitory effect on fibroblasts.

Conclusion

·G4 PAMAM can significantly increase the solubility of IBU and improve its drug effect; the G4 PAMAM-IBU/GelMA hydrogel has a sustained drug release behavior responding to MMP and can inhibit the proliferation of fibroblasts sustainably.

Key words： hydrogel; generation 4 polyamindoamine (G4 PAMAM); ibuprofen (IBU); peritendinous adhesion

参考文献

1 Jaibaji M. Advances in the biology of zone Ⅱ flexor tendon healing and adhesion formation[J]. Ann Plast Surg, 2000, 45(1): 83-92.
2 James R, Kesturu G, Balian G, et al. Tendon: biology, biomechanics, repair, growth factors, and evolving treatment options[J]. J Hand Surg, 2008, 33(1): 102-112.
3 Zeng J, Xu X, Chen X, et al. Biodegradable electrospun fibers for drug delivery[J]. J Control Release, 2003, 92(3): 227-231.
4 Verreck G, Chun I, Rosenblatt J, et al. Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer[J]. J Control Release, 2003, 92(3): 349-360.
5 Blomgran P, Blomgran R, Ernerudh J, et al. Cox-2 inhibition and the composition of inflammatory cell populations during early and mid-time tendon healing[J]. Muscles Ligaments Tendons J, 2017, 7(2): 223-229.
6 Yang DJ, Xiong CD, Govender T, et al. Preparation and drug-delivery potential of metronidazole-loaded PELA tri-block co-polymeric electrospun membranes[J]. J Biomater Sci Polym Ed, 2009, 20(9): 1321-1334.
7 Liu S, Hu C, Li F, et al. Prevention of peritendinous adhesions with electrospun ibuprofen-loaded poly(L-lactic acid)-polyethylene glycol fibrous membranes[J]. Tissue Eng Part A, 2013, 19(3-4): 529-537.
8 Irvine J, Afrose A, Islam N. Formulation and delivery strategies of ibuprofen: challenges and opportunities[J]. Drug Dev Ind Pharm, 2018, 44(2): 173-183.
9 Wan Y, Chen W, Yang J, et al. Biodegradable poly(L-lactide)-poly(ethylene glycol) multiblock copolymer: synthesis and evaluation of cell affinity[J]. Biomaterials, 2003, 24(13): 2195-2203.
10 Fan CX, Shi JJ, Zhuang Y, et al. Myocardial-infarction-responsive smart hydrogels targeting matrix metalloproteinase for on-demand growth factor delivery[J]. Adv Mater, 2019, 31(40): e1902900.
11 Loiselle AE, Bragdon GA, Jacobson JA, et al. Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression[J]. J Orthop Res, 2009, 27(6): 833-840.
12 程若昱, 燕宇飞, 陈皓, 等. 双效骨诱导性的有机-无机水凝胶的构建及其骨再生研究[J]. 上海交通大学学报(医学版), 2018, 38(8): 900-909.
13 Ribeiro JS, Bordini EAF, Ferreira JA, et al. Injectable MMP-responsive nanotube-modified gelatin hydrogel for dental infection ablation[J]. ACS Appl Mater Interfaces, 2020, 12(14): 16006-16017.
14 Tan V, Nourbakhsh A, Capo J, et al. Effects of nonsteroidal anti-inflammatory drugs on flexor tendon adhesion[J]. J Hand Surg Am, 2010, 35(6): 941-947.
15 Yang J, Li K, He D, et al. Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines[J]. Drug Metab Rev, 2020, 52(1): 19-43.
16 Bilia AR, Piazzini V, Risaliti L, et al. Nanocarriers: a successful tool to increase solubility, stability and optimise bioefficacy of natural constituents[J]. Curr Med Chem, 2019, 26(24): 4631-4656.
17 Li J, Liang H, Liu J, et al. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy[J]. Int J Pharm, 2018, 546(1-2): 215-225.
18 Geiger BC, Wang S, Padera RF Jr, et al. Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis[J]. Sci Transl Med, 2018, 10(469): eaat8800.
Options
文章导航

/

〈 〉